’Όόγ‚Ι”z’u
@Achievements @@Members
@@Gallery

‹ΖΡˆκ——

2011”N

1DNakayama T, Takeuchi D, Akeda Y, Oishi K. Streptococcus suis infection induces bacterial accumulation in the kidney. Microb Pathog 50:87-93, 2011

2DEzoe H, Akeda Y, Piao Z, Aoshi T, Koyama S, Tanimoto T, Ken J. Ishii KJ, Oishi K. Intranasal vaccination with pneumococcal surface protein A plus poly(I:C) protects against secondary pneumococcal pneumonia in mice. Vaccine 29:1754-1761,2011

3DKerdsin A, Dejsirilert S, Puangpatra P, Sripakdee S, Chumla K, Boonkerd N, Polwichai P, Tanimura S, Takeuchi D, Nakayama T, Nakamura S, Akeda Y, Gottschalk M, Sawanpanyalert P, Oishi K. Genotypic profile of Streptococcus suis serotype 2 and clinical features of infection in humans, Thailand. Emerg Infect Dis 17:835-842, 2011.

4D
Piao Z, Oma K, Ezoe H, Akeda Y, Tomono K, Oishi K. Comparative effects of toll-like receptor agonists on a low dose PspA intranasal vaccine against fatal pneumococcal pneumonia in mice. J Vaccines Vaccin 2:1, 2011 htt://dx.doi.org/10.4172/2157-7560.1000113


5DYoshii H, Kamiyama H, Goto K, Oishi K, Katunuma N, Tanaka Y,Hayashi H, Matsuyama T, Sato H, Yamamoto N, Kubo Y. CD4-independent human immunodeficiency virus infection involves participationof endocytosis and cathepsin B. PLoS One, 6 (4):e19352, 2011

6DKataoka K, Fujihashi K, Oma K, FukuyamaY, Hollingshead SK, Fukui M, Sekine S, KawabataS, Ito H, Briles DB, Oishi K. Nasal dendritic cell targeting Flt3 ligand as a safe adjuvant elicits effectiveprotection against fatal pneumococcal pneumonia. Infect Immun, 79: 2819-2828,2011

7DKerdsin A, Dejsirilert S, SawanpanyalertP, Boonnark A, Noithachang W, Sriyakun D, SimkumS, Chokngam S,  Gottschalk M, Akeda Y, Oishi K. Sepsis and spontaneous bacterial peritonitis in Thailand. Lancet 378:960,2011

8DAkeda, Y, Kodama T, Saito K, Iida T, Oishi, K,Honda T. Identification of the Vibrio parahaemolyticus Type III SecretionSystem 2-Associated Chaperone VocC for the T3SS2-specific effector VopC. FEMSMicrobiol Lett (in press).

2010”N

1DInoue S, Alonzo MTG, Kurosawa Y, Mapua CA, Reyes JD, Dimaano EM, Alera MTP, Saito M, Oishi K, Hasebe F, Matias RR, Natividad FF, Morita K. Evaluation of a dengue IgG-indirect ELISA and a Japanese encephalitis IgG-indirect ELISA for diagnosis of secondary dengue virus infection. Vector-Borne and Zoonotic Dis 10: 143-150, 2010

2DKerdsin A, Uchida R, Verathamjamrus C, Puangpatra P, Kawakami K, Pathom Sawanpanyalert P, Dejsirilert S, Oishi K. Development of triplex SYBR green real-time PCR for detecting Mycoplasma pneumoniae, Chlamydophila pneumoniae and Legionella spp., without extraction of DNA. Jap J Infect Dis 63: 173-180, 2010

3DChampunot R, Tanjatham S, Kerdsin A, Parichart Puangpatra P,  Wangsai S, Treebuphachatsakul P,  Tasnsuphaswasdikul S, Kiatvitchukul C, Kasyanan H, Yimsabai J, Akeda Y, Kawakami K, Sawanpanyalert P, Dejsirilert S, Oishi K. Impact of severity of pandemic influenza (H1N1) virus-associated community-acquired pneumonia among adults in a tertiary hospital in Thailand. Jap J Infect Dis, 63:251-256,2010

4DFukuyama Y, King JD, Kataoka K, Kobayashi R, Gilbert RS, Oishi K, Hollingshead SK, Briles DE, Fujihashi K. Secretory IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol, 185:1755-1762, 2010

5DKawakami K, Ohkusa Y, Kuroki R, Tanaka T, Koyama K, Harada Y, Iwanaga K, Yamaryo T, Oishi K. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine, 28:7063-7069, 2010

2009”N

1. Kerdsin, A., Oishi, K., Sripakdee, S., Boonkerd,N., Polwichai, P., Nakamura, S., Uchida, R., Sawanpanyalert,P., Dejsirilert, S. (2009) ClonalDissemination of Streptococcus suis serotype14 in Thailand. J Med Microbiol 58:1508-1513.

2. Honda, S.,Saito, M., Dimaano, E. M., Morales, P. A., Alonzo, M. T. G., Suarez, L. C.,Koike, N., Inoue, S., Kumatori, A., Matias, R.R., Natividad, F. F., Oishi, K.(2009). Increased platelet phagocytosis frompatients with secondary dengue virus Infection by human macrophages. Am J TropMed Hyg 80:841-845.


3. Akeda,Y., Okayama, K., Kimura, T., Dryselius, R., Kodama, T., Oishi, K., Iida, T.,Honda, T. (2009). Identification and characterization of a type IIIsecretion-associated chaperone in the type III secretion 1 of Vibrio parahaemolyticus. FEMS MicrobiolLett. 296:18-25.

4. Oma, K., Zhao, J., Ezoe, H.,Akeda, Y., Koyama, S., Ishii, K. J., Kataoka, K., Oishi, K. (2009). Intranasalimmunization with a mixture of PspA and a Toll-like receptor agonist inducesspecific antibodies and enhances bacterial clearance in the airways of mice.Vaccine 27:3181-3188.

2008”N

1DChen, M., Ssali, F., Mulungi, M., Awio, P.,Yoshimine, H., Kuroki, R., Furumoto, A., Tanimura,S., Kityo, C., Nagatake, T., Mugyenyi, P.,Oishi, K. (2008) Induction of opsonophagocytic killing activity withpneumococcal conjugate vaccine in human immunodeficiency virus-infected Ugandanadults. Vaccine. 26:4962-4968.

2DFurumoto, A., Ohkusa,Y., Chen, M., Kawakami, K., Masaki, H., Sueyasu, Y.,Iwanaga, T., Aizawa, H., Nagatake, T., and Oishi, K. (2008).Additive effect of pneumococcal vaccine and influenza vaccine on acuteexacerbation in patients with chronic lung disease. Vaccine. 26:4284-4289.

3. Furumoto, A., Ohkusa, Y., Chen, M., Kawakami,K., Masaki, H., Sueyasu, Y., Iwanaga, T., Aizawa, H., Nagatake, T.,and Oishi, K. (2008). Additive effect of pneumococcal vaccine andinfluenza vaccine on acute exacerbation in patients with chronic lung disease.Vaccine. 26:4284-4289.

4. Chen M, Ssali F, Mulungi M, Awio P, YoshimineH, Kuroki R,  Furumoto A, Tanimura S, KityoC, Nagatake T, Mugyenyi P, Oishi K. (2008) Induction of opsonophagocytic killing activitywith pneumococcal conjugate vaccine in human immunodeficiency virus-infectedUgandan adults. Vaccine

5. Watanabe K, Anh DD, Huong PH, Nguyet NT, Anh NTH, Thi NT, Dung NT,Phong DM, Rusizoka OS, Nagatake T, Watanabe H, Oishi K. Drug-resistantpneumococci in children with acute lower respiratory infections in Vietnam.Pediatrics International
(2008)

2007”N

1. Qin L, Watanabe H, Asoh N, Watanabe K, Oishi K, Mizota T, and NagatakeT (2007). Antimicrobial susceptibility and genetic characteristics of Haemophilusinfluenzae isolated from patients with respiratory tract infections between1987 and 2000, including b-lactamase-negative ampicillin-resistant strains.Epidemiol Infect, 135:665-668, 2007.

2. Koyama J, Ahmed K, Zhao J, Saito M, Onizuka S, Oma K, Watanabe K, WatanabeH, Oishi K (2007). Strain-specific pulmonary defense achieved after repeatedairway immunizations with non-typeable Haemophilus influenzae in a mousemode.Tohoku J Exp Med. 211:63-79.

3. Watanabe H, Batuwanthudawe R, Thevanesam V, Kaji C, Qin L, Nishikiori N,Saito W, Saito M, Watanabe K, Oishi K, Abeysinghe N, Kunii O (2007) Possible prevalence and transmission of acute respiratory tract infectionscaused by Streptococcus pneumoniae and Haemophilus influenzae among theinternally displaced persons in tsunami disaster evacuation camps of SriLanka. Intern Med. 46(17):1395-402, 2007.

4. Anh DD, Huong PLT, Watanabe K, Nguyet NT,Anh NTH, Thi NT, Dung NT, Phuong DM, Tanimura S, Ohkusa Y, Nagatake T, WatanabeH, Oishi K (2007). Increased rates of intense nasopharyngeal bacterialcolonization of Vetnamese Children with radiological pneumonia. Tohoku J ExpMed 213: 167-172.

5. Chen, M., Hisatomi,Y., Furumoto, A., Kawakami, K., Masaki, H., Nagatake, T., Sueyoshi, Y.,Iwanaga, T., Aizawa, M., and Oishi, K. (2007).
Comparativeimmune response of patients with chronic pulmonary diseases during the 2-yearperiod after pneumococcal vaccination. Clin. Vac. Immunol. 14, 139-145.

6. Oishi K, Saito M, Mapua C.A, Natividad F.F. Dengue illness: clinicalfeatures and pathogenesis. J Infect Chemother. 13:125-133, 2007

7. Dimaano E, Saito M, Honda S,Miranda EA, Alonzo MT, Valerio MD, MapuaCD, Inoue S, Kumatori A, Matias R,Natividad FF, Oishi K. Lack of efficacy ofhigh dose intravenous immunoglobulin treatment of severethrombocytopenia inpatients with secondary dengue virus@infection. Am JTrop Med Hyg 77: 1135-1138, 2007

2006”N

1. Kurita, S., Koyama, J., Onizuka, S., Motomura, K., Watanabe, H., Watanabe, K., Senba, M., Apicella, M.A., Murphy, T.F., Matsushima, K., Nagatake, T., and Oishi, K. (2006). Dynamics of dendritic cell migration and the subsequent induction of protective immunity in the lung after repeated airway challenges by nontypeable Haemophilus influenzae outer membrane protein. Vaccine. 24, 5896-5903.

2. Oishi K, Yoshimine H, Watanabe H, Watanabe K, Tanimura S, Kawakami K, Iwagaki A, Nagai H, Goto H, Kudoh S, Kuriyama T, Fukuchi Y, Matsushima T, Shimada K, Matsumoto K, and Nagatake T (2006). Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan. Respirology, 11:429-436.

3. Qin L, Watanabe H, Yoshimine H, Guio H, Watanabe K, Kawakami K, Iwagaki A, Nagai H, Goto H, Kuriyama T, Fukuchi Y, Matsushima T, Kudoh S, Shimada K, Matsumoto K, Nagatake T, Oishi K (2006). Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan. Epidemiol. Infect 134:1188-1194.

4.Oishi K, Mapua CA, Carlos CC, Cinco-Abanes MT.D.D, Saito M,Inoue S, Morita K, Natividad F.F. Dengue and other febrile illnessesamong children in the Philippines. WHO Dengue Bulletin, 30: 26-34, 2006

2005”N

1. Carlos CC, Oishi K, Cinco MTDD, Mapua CA, Inoue S, Cruz DJM, PanchoMAN, Tanig CZ, Matias RR, Morita K, Natividad FF, Igarashi A, NagatakeT. Comparison of clinical features including hematological abnormalitiesbetween dengue fever and dengue hemorrhagic fever among children in thePhilippines. Am J Trop Med Hyg, 73: 435-440, 2005.

2004”N


1. Saito M, OishiK, Inoue S, Dimaano EM, Alera MTP, Robles MP, Estrella,JR,Kumatori A, Moji K,Alonzo BMT, Buerano CC, Matias RR, Morita K, NatividadFF, Nagatake T.Association of increased platelet-associated immunoglobulinswiththrombocytopenia and the severity of disease in secondary denguevirusinfections.Clin. Exp. Immunol, 138:299-303,2004.


2003”N

1. Oishi K, Inoue S, Cinco MT, Dimaano EM,Alera MT, Alfon JA, Abanes F, Cruz DJ, Matias RR, Matsuura H, Hasebe F,Tanimura S, Kumatori A, Morita K, F.F. Natividad FF, Nagatake T. Correlationbetween increased platelet-associated IgG and thrombocytopenia in secondarydengue virus infections. J Med Virol 71:259-64, 2003


@@@@@@@@@@@@@@@@@@@

’Όόγ‚Ι”z’u